<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To define optimal time for transplantation of bone marrow (TBM) in children with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: 20 allogenic TBMs were performed in children with <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (6 patients, 2 of them in recurrence), <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (7 patients, 4 of them in recurrence), <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) in a <z:hpo ids='HP_0011010'>chronic</z:hpo> stage (3 patients), severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (3 patients), generalized <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> (1 patient) </plain></SENT>
<SENT sid="2" pm="."><plain>Pretransplantation preparation included <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and busulphane or <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, busulphane and vepezide </plain></SENT>
<SENT sid="3" pm="."><plain>The graft-versus-host reaction (GVHR) was prevented with <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> plus <z:chebi fb="0" ids="44185">methotrexate</z:chebi> or <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> plus urbazone </plain></SENT>
<SENT sid="4" pm="."><plain>Engrafting was recognized by change of karyotype and blood group </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: From 13 children with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> subjected to TBM in a complete remission 4(33%) are alive, 5 died within 100 days after TBM (TBM was made in recurrence in 4 children), 3 patients died of recurrence 12 months after TBM </plain></SENT>
<SENT sid="6" pm="."><plain>One patient with <z:mp ids='MP_0005481'>CML</z:mp> and one with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> remain in remission </plain></SENT>
<SENT sid="7" pm="."><plain>The main complications and causes of <z:hpo ids='HP_0011420'>death</z:hpo> in early posttransplantation period were hemorrhagic syndrome, infectious complications, GVHR </plain></SENT>
<SENT sid="8" pm="."><plain>According to a one-year follow-up, the <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> caused <z:hpo ids='HP_0011420'>death</z:hpo> most frequently </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Positive result of TBM is related to the disease stage at transplantation </plain></SENT>
</text></document>